Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden

Neuroepidemiology

Volumn 38, Issue 4, 2012, Pages 245-249

  Bostörm, Inger ^a   Riise, Trond ^d   Landtblom, Anne Marie ^a,b,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c General Hospital   (Sweden)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

Amyotrophic lateral sclerosis; Correlation; Mortality; Multiple sclerosis

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHILD; FEMALE; GROUPS BY AGE; HUMAN; MALE; MORTALITY; MULTIPLE SCLEROSIS; SCHOOL CHILD; SEX DIFFERENCE; SWEDEN;

AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; REGISTRIES; SWEDEN;

EID: 84861810534     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000338031     Document Type: Article

References (20)

1. Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K: Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 2009; 10: 5-11.
2. Landtblom AM, Riise T, Boiko A, Söderfeldt B: Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics. Neuroepidemiology 2002; 21: 167-179. (Pubitemid 34639045)
3. Kurtzke JF: On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand 1967; 43: 257-282.
4. Gunnarsson LG, Lindberg G, Söderfeldt B, Axelson O: The mortality of motor neuron disease in Sweden. Arch Neurol 1990; 47: 42-46. (Pubitemid 20024152)
5. Gunnarsson LG, Palm R: Motor neuron disease and heavy manual labour: An epidemiologic survey of Värmland County, Sweden. Neuroepidemiology 1984; 3: 195-206. (Pubitemid 15066274)
6. http://www.socialstyrelsen.se/register/dodsorsaksregistret (accessed 29 April 2010, 15 Nov 2011).
7. http://www.scb.se (accessed 15 May 2010, 15 Nov 2011).
8. Hennekens CH, Buring JE: Epidemiology in Medicine. Boston, Little, Brown, 1987, pp 66-73.
9. Riise T, Nortvedt MW, Ascherio A: Smoking is a risk factor for multiple sclerosis. Neurology 2003; 8: 1122-1124. (Pubitemid 37461949)
10. Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al: Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort. Ann Neurol 2009; 4: 378-385.
11. Hawkes CH, Cavanagh B, Fox AJ: Motorneuron disease: A disorder secondary to solvent exposure? Lancet 1989;i:73-76. (Pubitemid 19033996)
12. Landtblom AM, Flodin U, Söderfeldt B, Wolfson C, Axelson O: Organic solvents and multiple sclerosis: A synthesis of the current evidence. Epidemiology 1996; 7: 429-433. (Pubitemid 26202191)
13. Landtblom AM: Exposure to organic solvents and multiple sclerosis. Neurology 1997; 49(2 suppl 2):S70-S74.
14. Lauer K: Environmental risk factors in multiple sclerosis. Expert Rev Neurother 2010; 10: 421-440.
15. Olsson T, Hillert J: The genetics of multiple sclerosis and its experimental models. Curr Opin Neurol 2008; 21: 255-260. (Pubitemid 351653973)
16. Ahlgren C, Odén A, Lycke J: High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011; 17: 901-908.
17. Johansson LA, Björkestam C, Westerling R: Unexplained differences between hospital and mortality data indicated mistakes in death certification: An investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009; 62: 1202-1209.
18. Fang F, Valdimarsdóttir U, Bellocco R, Ronnevi LO, Sparén P, Fall K, Ye W: Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol 2009; 66: 515-519.
19. Malmgren M, Valdiviezo NL, Visscher BR, Clark VA, Detels R, Fukumoto M, Dudley JP: Underlying causes of death as recorded for multiple sclerosis: Associated factors. J Chronic Dis 1983; 36: 699-705. (Pubitemid 14246891)
20. Goldacre MJ, Duncan ME, Cook-Mozzafari P, Griffit M: Trends in mortality rates comparing underlying-causes and multiplecause coding in an English population 1979-1998. J Publ Health Med 2003; 25: 249-253.